Interview, Fireside Chat
Dr. Tony Coles, President, CEO and Chairperson of Cerevel Therapeutics
- The biopharmaceutical sector is projected to enter a "platinum age of science" where breakthroughs arrive at a "breakneck speed," accelerating the search for vaccines.
- Consumerism trends initiated in the 2000s are expected to persist, driving increased information transfer to consumers to facilitate dialogue with physicians.
- Discourse surrounding pricing, reimbursement, and value chains is anticipated to necessitate greater transparency in both therapy development and operational value chains.
- Technological advancements are forecast to displace an estimated 60% of jobs, a shift that disproportionately affects African Americans.
- Without specific interventions concerning technology and employment, the unemployment rate for Black Americans is projected to rise to between 20% and 25% by 2030.
- Business leaders are expected to face sustained public scrutiny, with 60% of respondents indicating they will purchase from or boycott companies based on their response to national unrest.
- Approximately 70% of adults aged 50 and older are expected to believe businesses have a moral obligation to host, drive, and affect change regarding social issues.
- Companies failing to reconcile with current social topics are considered likely to suffer negative revenue impacts and risk being left behind.
- The business community is expected to maintain a clear and ongoing public voice on social debates, with no expectation of retreating from these engagements.
- The process of addressing 400 years of systemic racism is characterized as a difficult undertaking that is unlikely to be achieved overnight.